Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$84.52
1.101.32%
Last update: Oct 2, 9:25 AM
$84.31
0.891.07%
Oruka Therapeutics Inc (ORKA) Stock Price, Quote, News & History
ORKANASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Oruka Therapeutics (NASDAQ:ORKA) through any online brokerage.
Other companies in Oruka Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Oruka Therapeutics has a consensus price target of $87.06.
The stock price for Oruka Therapeutics (NASDAQ: ORKA) is $84.31 last updated October 2, 2026 at 9:25 AM EDT.
There are no upcoming dividends for Oruka Therapeutics.
Oruka Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Oruka Therapeutics.
Oruka Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
